
Opinion|Videos|May 12, 2025
Implementing Lp(a) Testing: Learning From LDL Testing and Considering Value-Based Care Models
Experts discuss lessons learned from implementing lipid-lowering therapy recommendations and explore the role value-based care models may play in successfully adopting the National Lipid Association’s (NLA) recommendation for lipoprotein(a) (Lp[a]) testing.
Advertisement
Video content above is prompted by the following:
In following the NLA recommendation, what lessons can we learn from our experience implementing recommendations for lipid-lowering therapies?
What role might value-based care models play in implementing the NLA recommendation?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Giredestrant Regimen for ESR1-Mutated Breast Cancer
2
Hepatitis B Screening Gaps Persist as Functional Cure Option Arrives
3
IgA Nephropathy, FSGS Care Needs Coordinators, Not Just New Drugs
4
FDA Approves Secukinumab as First Anti–IL-17 Biologic for PMR
5


